RE:RE:RE:RE:RE:RE:RE:RE:RE:What’s going on?I don't worry about the CAN wall yesterday, seen this before as a means to make sure that options/warrants issued to management are favourable as calculation is based on average price during a period of time.
One can only speculate about the sellout in Germany today. Within two weeks we should get announcement about the anti-aging clinical trial, an update by means of letter to shareholders and potentially get some insight of the abbvie deal (we don't know when the invoice was cut). Maybe someone was scared of the CAN wall, maybe someone needed the funds to finance something or whatever.
If you deem that company value will be added during the last quarter it's a great opportunity to buy, but I warn you - the investment might double overnight...